40.62
price down icon0.47%   -0.19
 
loading
Schlusskurs vom Vortag:
$40.81
Offen:
$41.15
24-Stunden-Volumen:
201.38K
Relative Volume:
0.41
Marktkapitalisierung:
$2.02B
Einnahmen:
$499.95M
Nettoeinkommen (Verlust:
$-36.36M
KGV:
-52.75
EPS:
-0.77
Netto-Cashflow:
$24.22M
1W Leistung:
-1.91%
1M Leistung:
+22.50%
6M Leistung:
+28.50%
1J Leistung:
+34.28%
1-Tages-Spanne:
Value
$40.40
$41.52
1-Wochen-Bereich:
Value
$40.40
$42.60
52-Wochen-Spanne:
Value
$28.29
$43.11

Atricure Inc Stock (ATRC) Company Profile

Name
Firmenname
Atricure Inc
Name
Telefon
513-755-4100
Name
Adresse
7555 INNOVATION WAY, MASON, OH
Name
Mitarbeiter
1,300
Name
Twitter
@AtriCure
Name
Nächster Verdiensttermin
2024-10-29
Name
Neueste SEC-Einreichungen
Name
ATRC's Discussions on Twitter

Vergleichen Sie ATRC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
ATRC
Atricure Inc
40.65 2.03B 499.95M -36.36M 24.22M -0.77
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
563.41 197.40B 9.61B 2.77B 2.27B 7.555
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
194.66 55.76B 21.84B 1.68B 2.67B 5.8293
Medical Instruments & Supplies icon
ALC
Alcon Inc
79.76 38.93B 10.19B 1.05B 1.38B 2.1044
Medical Instruments & Supplies icon
RMD
Resmed Inc
242.35 35.90B 5.26B 1.44B 1.76B 9.7713
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
268.81 19.36B 2.96B 487.70M 344.00M 6.6758

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-17 Fortgesetzt JP Morgan Overweight
2024-04-23 Hochstufung Oppenheimer Perform → Outperform
2023-10-23 Eingeleitet JMP Securities Mkt Outperform
2023-09-29 Eingeleitet UBS Buy
2021-08-05 Herabstufung Oppenheimer Outperform → Perform
2020-12-18 Bestätigt Needham Buy
2020-11-06 Bestätigt Needham Buy
2020-04-07 Eingeleitet Oppenheimer Outperform
2020-02-06 Eingeleitet BTIG Research Buy
2020-01-24 Bestätigt Needham Buy
2019-08-13 Herabstufung Northland Capital Outperform → Market Perform
2019-04-12 Eingeleitet JP Morgan Overweight
2018-10-04 Bestätigt Needham Buy
2018-08-02 Bestätigt Needham Buy
2018-08-02 Bestätigt Stifel Buy
2018-06-18 Bestätigt Needham Buy
2018-04-27 Bestätigt Needham Buy
2018-01-16 Bestätigt Needham Buy
2017-11-02 Bestätigt Needham Buy
2017-07-28 Bestätigt Needham Buy
2017-05-30 Fortgesetzt Piper Jaffray Overweight
2016-06-30 Fortgesetzt JMP Securities Mkt Outperform
2015-10-28 Bestätigt Needham Buy
2015-10-06 Bestätigt Canaccord Genuity Buy
2015-10-06 Bestätigt Needham Buy
Alle ansehen

Atricure Inc Aktie (ATRC) Neueste Nachrichten

pulisher
04:11 AM

AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference - BioSpace

04:11 AM
pulisher
Dec 17, 2025

Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way? - 富途牛牛

Dec 17, 2025
pulisher
Dec 16, 2025

JPMorgan Chase & Co. Boosts AtriCure (NASDAQ:ATRC) Price Target to $48.00 - MarketBeat

Dec 16, 2025
pulisher
Dec 16, 2025

JP Morgan Raises AtriCure (ATRC) Price Target to $48 | ATRC Stoc - GuruFocus

Dec 16, 2025
pulisher
Dec 16, 2025

AtriCure price target raised to $48 from $42 at JPMorgan - TipRanks

Dec 16, 2025
pulisher
Dec 15, 2025

AtriCure, Inc. $ATRC Shares Acquired by Squarepoint Ops LLC - MarketBeat

Dec 15, 2025
pulisher
Dec 14, 2025

AtriCure (ATRC) Is Up 6.3% After First Dual-Energy PFA–RFA Human Procedures Success - Sahm

Dec 14, 2025
pulisher
Dec 13, 2025

AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human SuccessHas The Bull Case Changed? - Yahoo Finance

Dec 13, 2025
pulisher
Dec 12, 2025

Loss Report: What valuation multiples suggest for AtriCure Inc stockJuly 2025 Outlook & Fast Entry Momentum Alerts - moha.gov.vn

Dec 12, 2025
pulisher
Dec 12, 2025

AtriCure treats first patients with dual PFA/RF system - MedTech Dive

Dec 12, 2025
pulisher
Dec 12, 2025

ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform - Finviz

Dec 12, 2025
pulisher
Dec 12, 2025

Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year? - MSN

Dec 12, 2025
pulisher
Dec 11, 2025

AtriCure reports first patients treated with dual-energy PFA, RF platform - MassDevice

Dec 11, 2025
pulisher
Dec 11, 2025

AtriCure Announces the First Patients Treated with Novel Dual Energy Platform - 01net

Dec 11, 2025
pulisher
Dec 11, 2025

AtriCure, Inc. Announces the First Patients Treated with Novel Dual Energy Platform - marketscreener.com

Dec 11, 2025
pulisher
Dec 11, 2025

AtriCure Reports 1st Treatments with Dual Energy RF, PFA System - Medical Product Outsourcing

Dec 11, 2025
pulisher
Dec 11, 2025

AtriCure Says First Patients Treated With Dual-Energy Platform - marketscreener.com

Dec 11, 2025
pulisher
Dec 11, 2025

AtriCure (ATRC) Introduces Cutting-Edge Dual Energy Platform in Initial Treatments - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

AtriCure, Inc.'s (NASDAQ:ATRC) 29% Share Price Surge Not Quite Adding Up - simplywall.st

Dec 11, 2025
pulisher
Dec 11, 2025

Russell Investments Group Ltd. Decreases Stake in AtriCure, Inc. $ATRC - MarketBeat

Dec 11, 2025
pulisher
Dec 08, 2025

Are Medical Stocks Lagging AtriCure (ATRC) This Year? - Yahoo Finance

Dec 08, 2025
pulisher
Dec 08, 2025

Hood River Capital Management LLC Has $100.31 Million Holdings in AtriCure, Inc. $ATRC - MarketBeat

Dec 08, 2025
pulisher
Dec 05, 2025

Will AtriCure Inc. stock deliver strong dividend growthPortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser

Dec 05, 2025
pulisher
Dec 03, 2025

Why analysts remain bullish on AtriCure Inc. stock2025 Trading Recap & Consistent Growth Stock Picks - Newser

Dec 03, 2025
pulisher
Nov 30, 2025

AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 30, 2025
pulisher
Nov 30, 2025

Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? - AOL.com

Nov 30, 2025
pulisher
Nov 28, 2025

AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance - MSN

Nov 28, 2025
pulisher
Nov 28, 2025

Geode Capital Management LLC Purchases 14,577 Shares of AtriCure, Inc. $ATRC - MarketBeat

Nov 28, 2025
pulisher
Nov 27, 2025

How supply chain issues affect AtriCure Inc. stockJuly 2025 Volume & Scalable Portfolio Growth Methods - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 27, 2025

Insider Selling: AtriCure (NASDAQ:ATRC) Director Sells 4,967 Shares of Stock - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

Atricure Executives Make Significant Stock Sales - TipRanks

Nov 26, 2025
pulisher
Nov 26, 2025

Insider Sell: Justin Noznesky Sells 5,166 Shares of AtriCure Inc (ATRC) - GuruFocus

Nov 26, 2025
pulisher
Nov 26, 2025

AtriCure Executives Engage in Stock Transactions - TradingView

Nov 26, 2025
pulisher
Nov 26, 2025

Atricure Insider Sold Shares Worth $376,578, According to a Recent SEC Filing - MarketScreener

Nov 26, 2025
pulisher
Nov 26, 2025

Dir Wehrwein Sells 10,000 ($376.6K) Of AtriCure Inc [ATRC] - TradingView

Nov 26, 2025
pulisher
Nov 26, 2025

Officer Noznesky Sells 5,166 ($192.6K) Of AtriCure Inc [ATRC] - TradingView

Nov 26, 2025
pulisher
Nov 26, 2025

ATRC Form 4: Director exercises $19.95 options, trims holdings - Stock Titan

Nov 26, 2025
pulisher
Nov 26, 2025

[Form 4] AtriCure, Inc. Insider Trading Activity - Stock Titan

Nov 26, 2025
pulisher
Nov 26, 2025

Precision Trading with Atricure Inc. (ATRC) Risk Zones - news.stocktradersdaily.com

Nov 26, 2025
pulisher
Nov 26, 2025

Officer Noznesky Files To Sell 5,166 Of AtriCure Inc [ATRC] - TradingView

Nov 26, 2025
pulisher
Nov 26, 2025

Atricure Director Makes a Significant Stock Sale! - TipRanks

Nov 26, 2025
pulisher
Nov 26, 2025

AtriCure director Yuen sells $107k in shares By Investing.com - Investing.com Australia

Nov 26, 2025
pulisher
Nov 25, 2025

Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to Trade - Finviz

Nov 25, 2025
pulisher
Nov 25, 2025

Insider Sell: Maggie Yuen Sells 3,000 Shares of AtriCure Inc (AT - GuruFocus

Nov 25, 2025
pulisher
Nov 25, 2025

AtriCure director Yuen sells $107k in shares - Investing.com

Nov 25, 2025
pulisher
Nov 25, 2025

AtriCure Director Maggie Yuen Sells 3,000 Shares - TradingView

Nov 25, 2025
pulisher
Nov 24, 2025

Dir Wehrwein Files To Sell 5,033 Of AtriCure Inc [ATRC] - TradingView

Nov 24, 2025

Finanzdaten der Atricure Inc-Aktie (ATRC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_instruments_supplies BAX
$19.18
price down icon 0.65%
$161.29
price up icon 0.44%
$80.57
price up icon 0.81%
medical_instruments_supplies COO
$82.29
price down icon 0.24%
$74.95
price up icon 0.03%
medical_instruments_supplies WST
$268.61
price down icon 0.20%
Kapitalisierung:     |  Volumen (24h):